Page last updated: 2024-08-16

ro 31-8220 and ascorbic acid

ro 31-8220 has been researched along with ascorbic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T1
Lenti, L; Lo Coco, E; Paola, SG; Pignatelli, P; Sanguigni, V; Violi, F1

Trials

1 trial(s) available for ro 31-8220 and ascorbic acid

ArticleYear
Vitamin C inhibits platelet expression of CD40 ligand.
    Free radical biology & medicine, 2005, Jun-15, Volume: 38, Issue:12

    Topics: Adult; Antioxidants; Arachidonic Acids; Ascorbic Acid; Blood Platelets; CD40 Ligand; Collagen; Female; Gene Expression; Humans; Indoles; Male; Phospholipases A; Protein Kinase C; Superoxides; Thrombin

2005

Other Studies

1 other study(ies) available for ro 31-8220 and ascorbic acid

ArticleYear
Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
    Atherosclerosis, 2001, Volume: 155, Issue:1

    Topics: Acetylcysteine; Aldehydes; Animals; Antioxidants; Aorta, Thoracic; Arteriosclerosis; Ascorbic Acid; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Drug Synergism; Hydroquinones; Indoles; Lipid Peroxidation; Lysergic Acid; Male; Mitogens; Muscle, Smooth, Vascular; Pertussis Toxin; Protein Kinase C; Protein-Tyrosine Kinases; Rabbits; Serotonin; Serotonin Antagonists; Virulence Factors, Bordetella; Vitamin E

2001